Blog

Picking Up The Pieces In Stem Cell Therapy – Seeking Alpha


FierceBiotech

Picking Up The Pieces In Stem Cell Therapy
Seeking Alpha
Anyone with the fixed idea that stem cells are of no use in heart failure would have found little to dissuade them in two presentations at the European Society of Cardiology meeting in Rome on Sunday. Celyad's (OTC:CLYYF) phase III trial Chart-1 was
CardioCell stem cells 'improve well-being' of heart failure patientsFierceBiotech


CardioCell Reports Positive Results From the First Phase IIa Clinical Trial Using IV Administration of Stem Cells PR Newswire (press release)

all 5 news articles »

2016-08-29 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.